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Abstract  
AIM: The mains topics of this work are the incidence of patient-prosthesis mismatch and the 
influence in the early results of isolated aortic valve surgery. 
METHODS: In 193 patients isolated aortic valve surgery was performed. The study population was 
divided in three subgroups: 20 patients with severe, 131 patients with moderate and 42 patients 
without patient-prosthesis mismatch. The indexed effective orifice area was used to define the 
subgroups. Operative mortality and perioperative complications were considered the indicators of 
the early results of aortic valve surgery. 
RESULTS: The incidence of severe and moderate patient-prosthesis mismatch was respectively 
10.3% and 67.8%. Hospital mortality and perioperative complications were: mortality 5% vs. 3.1% 
vs. 2.4% (p = 0.855), low cardiac output 5% vs. 6.9% vs. 4.8% (p = 0.861); pulmonary 
complications 5% vs. 3.1 vs. 0.0% (p = 0.430); exploration for bleeding 5% vs. 0.8% vs. 2.4% (p = 
0.319); atrial fibrillation 30% vs. 19.8% vs. 11.9% (p = 0.225); wound infection 5% vs. 0.8% vs. 
0.00% (p = 0.165), respectively for the group with severe, moderate and without patient-prosthesis 
mismatch.  
CONCLUSIONS: Patient-prosthesis mismatch is a common occurrence in aortic valve surgery. 
This phenomenon does not affect the early results of aortic valve surgery. 
 
 
 
 
 
 
 
 
Introduction 
 
Patient prosthesis mismatch (PPM) is one of 
the most controversial issues related to the aortic 
valve replacement. It is introduced in 1978 by 
Rahimtoola as a condition in which the effective 
prosthetic valve area, after insertion into the patient, is 
less than that of a normal human valve [1]. There are 
two main occurrence factors of PPM: 
a) Effective orifice area “in vivo” and “in vitro” 
of the prosthesis; and 
  b) The patient's small native valve annulus.  
 In practical terms, to define PPM currently, 
the most used parameter is prosthetic effective orifice 
surface area indexed with the patient's body surface 
(EOAi). Based on this index, threshold for the 
appearance of PPM is 0.85 cm
2
/m
2
. Patient prosthesis 
mismatch has been classified as moderate when 0.65 
cm
2
/m
2
 ≤ EOAi ≤ 0.85cm
2
/m
2
 and severe when EOAi 
< 0.65 cm
2
/m
2
. 
Patient-prosthesis mismatch is a common 
occurrence after aortic valve replacement. The 
reported prevalence of moderate PPM varies between 
20–70%, whereas that of severe PPM is between 2% 
and 11% [2]. Nowadays, the discussion is still open 
about the impact of this phenomenon in the results of 
this kind of surgery.  
The mains topics of this work are the 
incidence of patient-prosthesis mismatch in aortic 
valve surgery and the influence of these findings in 
the early results. 
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Materials and Methods 
 
Our study was a prospective and 
retrospective study. All patients underwent isolated 
aortic valve surgery from January 2010 to January 
2015 in two cardiac surgery centres, public and non-
public, in Tirana (Service of Cardiac Surgery, UHC 
“Mother Theresa” and German Hospital). Patients who 
had additional surgical procedures were excluded 
from the study. Demographic data, intervention and 
postoperative data were collected from hospital 
records in the statistics office. Preoperative evaluation 
of risk of intervention was made according to 
EUROSCORE [5]. Surgical indication for aortic valve 
surgery was decided according to ESC and AHA/ACC 
guidelines [6, 7]. Indexed effective orifice area was 
used to define the degree of PPM. The effective 
orifice area of the prosthesis was taken from the 
reference prosthesis tables [2-4] while BSA was 
calculated according Du Bois and Du Bois formula. 
The body mass index was also recorded, which was 
calculated according to the metric formula (kg/m
2
). 
Hospital mortality and major complications such as 
low cardiac output, cerebral accidents, pulmonary 
complications, renal disorders, wound infection etc. 
were considered end-points for the evaluation of early 
results of aortic valve surgery. 
 
Surgical Procedure 
A full midline sternotomy was performed. After 
establishing cardiopulmonary bypass and clamping 
the aorta, myocardial protection was provided by 
intermittent antegrade cardioplegia. We used to do the 
first dose crystalloid and after warm blood 
cardioplegia; transverse aortotomy; resection of the 
native aortic valve cusps and meticulous 
decalcification of the aortic annulus. All prosthesis 
were implanted with mattress technique, using 
double-armed, pleged-suported TiCron 2/0 sutures 
The heart was de-aired and the aortic clamp 
removed after the closure of the aorta. At the end of 
the operation the cannulas was removed and 
protamine was given. Temporary pacemaker (PM) 
wires, mediastinal, and pleural tubes were placed 
before chest closure. 
 
Statistical analysis 
Continuous data were presented at the mean value 
and standard deviation. Discrete data were presented 
in absolute value and percentage. Differences 
between the two groups for continuous quantitative 
variables were performed by ANOVA test one way, 
the Bonferoni procedure. Differences between groups 
for discrete variables were performed by Chi-Square 
test. Relations between variables were analyzed 
through Pearson correlation coefficient (for 
quantitative variables) and Kendall's Tau (for discrete 
variables). Presentation of the data was performed 
through simple and composed tables, as well as 
graphics like scatter diagram, bar-diagram and Box-
plott. Data analysis was performed with SPSS 
statistical package, version 20, (Statistical Package 
for Social Sciences). It was considered significant 
values of p ≤ 0.05. 
 
 
Results 
 
Patients 
In the study were included 193 patients that 
performed isolated aortic valve surgery. Patients were 
divided into three groups according to the degree of 
PPM: 20 patients with severe PPM; 131 patients with 
moderate PPM; and 42 patients without PPM. 
General demographic and clinical data are 
presented in Table 1.  
The mean population’s age was 59.53 ± 
12.73. Groups with PPM had significant higher mean 
age comparing to other groups; 124 patients (64.6%) 
were males. The incidence of co morbidities was 
without significant statistical differences among 
groups except diabetes mellitus and arterial 
hypertension that predominate in the group with the 
moderate PPM. BMI was importantly greater in groups 
with PPM. There were no significant differences in the 
preliminary calculation of intervention risk. 
Table 1: General demographic and clinical data 
General Data 
Groups PPM 
Total 
193 
 MPP severe 
n=20 
MPP moderate 
n=131 
No MPP 
n=42 Value p 
Age   63.55±11.97 60.47±12.47 54.69±12.83 59.53±12.73 0.012 
BMI   27.26±3.75 25.01±3.27 23.84±3.47 24.99±3.47 0.01 
BSA   1.85±0.13 1.79±0.16 1.75±0.20 1.79±0.17 0.10 
Gender M 9 82 33 124 
 
45.00% 63.10% 78.60% 64.60% 
F 11 48 9 69  
55.00% 36.90% 21.40% 35.40% 0.029 
Admission urgent 0 7 4 11 
 0.00% 5.30% 9.50% 5.70%  
planed 20 123 38 181 
 100.00% 93.90% 90.50% 93.80% 0.583 
NYHA II 6 32 6 45 
 30.00% 24.60% 14.60% 23.00% 
 III 12 90 34 137 
 60.00% 69.20% 82.90% 71.20%  
IV 2 8 1 11  
10.00% 6.20% 2.40% 5.80% 0.345 
 
HT 
  16 85 20 121 
 80.00% 64.90% 47.60% 62.70% 0.032 
 
DM 
  6 14 1 21 
 30.00% 10.70% 2.40% 10.90% 0.005 
 
AP 
  1 1 0 2 
 5.00% 0.80% 0.00% 1.00% 0.165 
 
Smoking 
  4 15 10 29 
 20.00% 11.50% 23.80% 15.00% 0.12 
 
COPD 
  1 5 0 6 
 5.00% 3.80% 0.00% 3.10% 0.406 
Esc Stand   4.90±1.66 4.23±2.19 4.03±2.33 4.23±2.18 0.554 
Esc Log   4.37±2.90 4.14±4.23 4.10±4.33 4.15±4.13 0.984 
 
BMI-body mass index; BSA-body surface area; HT-hypertension; DM-diabetes mellitus; 
AP-peripheral artheriopathi; COPD-chronic obstructive pulmonary diseases; Esc- 
Stand/Log-euro score standard/logistic. 
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Transthoracic echocardiography and 
transesophagical echocardiography were the main 
diagnostic tools. There were 121 patients (62.7%) with 
pure aortic stenosis; 44 patients (22.8%) with aortic 
insufficiency and the rest of the patients (had mixed 
pathology of aortic valve (28 pt. 14.5%)). 
Echocardiography data were presented in the Table 2. 
Table 2: Echocardiography data 
Data 
 
 
PPM severe 
 
 
MPP 
moderate 
 
 
No MPP 
 
 
 
 
Total Value p 
EF 
 
62.41±8.12 
 
59.86±10.37 
 
59.98±10.26 
 
60.14±10.12 0.623 
Anatomy Normal 18 
(90%) 
100 
82.6%) 
32 
80% 
156 
82.9% 
 
Bicuspid 2 21 8 37 
 10.00% 17.40% 20.00% 17.10% 0.621 
Ao Val Stenotic 18 83 20 121  
  
90.00 % 63.36 % 47.62 % 62.69 %  
 
Regurgit 1 28 15 44  
  
5.00% 21.37% 35.71% 22.80%  
 
Mixed 1 20 7 28  
  
5.00% 15.27% 16.67% 14.51% 0.023 
Calcified Annulus  
17 
85.00% 
84 
66.7% 
20 
51.3% 
121 
65.4% 0.031 
ThPW 12.82±0.99 13.21±2.02 12.53±1.98 13.01±1.94 0.222 
ThS 14.00±1.11 14.39±2.15 13.53±2.18 14.15±2.10 0.129 
LVTDD 53.75±6.77 57.59±8.20 59.70±8.76 57.74±8.31 0.107 
LVTSD 34.08±7.14 39.96±9.65 39.34±8.40 39.15±9.19 0.123 
Max Val grad 87.67±16.78 88.78±20.20 88.41±18.58 88.57±19.31 0.983 
Mean Val grad 48.31±8.84 52.45±13.77 55.65±7.41 52.43±12.55 0.220 
 
EF-ejection fraction; Ao Val-aortic valve; ThPW-thikness of posterior wall; ThS-thikness of 
septum LVTDD-left ventricle telediastolic diameter; LVTSD-left ventricle telesistolic 
diameter; Max Val grad-maximal aortic valve gradient; Mean Val grad-mean aortic valve 
gradient 
 
The echocardiography data showed that 
aortic stenosis was the dominant pathology (121/193 
pt, 62.7 %) in our population and annular calcification 
is encountered much more often in the PPM groups. 
Incidence of patient-prosthesis mismatch: 
incidence of severe PPM was 10.3% (20/193); and 
incidence of moderate PPM was 67.8% (131/193). 
Early mortality and postoperative 
complications:  overall mortality was 3.1% (6/193); 
mortality of the group with severe PPM was 5% (1/20 
pt); mortality of the group with moderate PPM was 
3.1% (4/131 pt); and mortality of the group without 
PPM was 2.4 % (1/42 pt). 
We can see that in absolute value, mortality in 
the groups with PPM is higher but this difference is 
not statistically significant (p = 0.855). The incidence 
of postoperative complications respectively for the 
group with severe PPM, moderate and without PPM 
was: low cardiac output 5% vs. 6.9% vs. 4.8%; 
pulmonary complications 5% vs. 3.1 vs. 0.0%; 
bleeding 5% vs. 0.8% vs. 2.4%; atrial fibrillation 30% 
vs. 19.8% vs. 11.9%; wound infection 5% vs. 0.8% vs. 
0.00%; ventricular arrhythmias 5 % vs. 4.6 % vs. 9.5 
%; conduction disturbances 10% vs. 6.9 % vs. 11.9 %  
There is a trend towards higher frequency of 
complications in the groups with PPM but the 
differences did not reach statistical significances 
(Table 3).  
Table 3: Mortality and postoperative complications 
Morality and complications 
Groups PPM 
Total n=193 
Value p 
 
PPM severe 
n=20 
PPM moderate 
n=131 
No PPM 
n=42 
Mortality 
1 
5.00% 
4 
3.10% 
1 
2.40% 
6 
3.10% 
0.855 
LCO 
1 9 2 12  
5.00% 6.90% 4.80% 6.20% 0.861 
Stroke 
0 1 0 1  
0.00% 0.80% 0.00% 0.50% 0.788 
Pulmonary 
1 4 0 5  
5.00% 3.10% 0.00% 2.60% 0.430 
RI 
0 1 1 2  
0.00% 0.80% 2.40% 1.00% 0.593 
Bleeding 
1 1 1 3  
5.00% 0.80% 2.40% 1.60% 0.319 
VA 
1 6 4 11  
5.00% 4.60% 9.50% 5.70% 0.480 
AF 
6 26 5 37  
30.00% 19.80% 11.90% 19.20% 0.225 
Wound inf 
1 1 0 2  
5.00% 0.80% 0.00% 1.00% 0.165 
Cond Dist  
2 9 5 16  
10.00% 6.90% 11.90% 8.30% 0.564 
LCO-low cardiac output; RI-renal insuficiency;VA-ventricular arrhythmias; AF-atrial 
fibrillation inf-infection;Cond Dist-conduction disturbances. 
 
Postoperative times in intensive care unit and 
hospital stay are longer in the group with PPM but the 
difference is not important. The mean prosthesis 
number used is 21.59 ± 1.88. It is clear the significant 
difference of mean prosthesis number between 
groups (p < 0.001). The maximal prosthesis gradient 
of the PPM groups are much higher in comparison 
with the group without PPM (p = 0.022) (Table 4). 
 
Table 4: Intervention and postoperative data 
Intervention and 
postoperative data 
PPM severe 
n=20 
PPM moderate 
n=131 
No PPM 
n=42 
Total Value p 
CPB 92.21±19.42 86.54±24.67 92.03±23.58 88.2930±23.93 0.379 
IT 78.67±23.57 68.93±22.42 66.77±21.84 9.43±22.51 0.163 
Resp Ass 
 
42.60±110.74 19.89±57.37 11.26±7.98 20.41±59.53 
 
ICU Stay (h) 97.9±13.9 65.83±10.1 51.14±26.24 65.96+9.6 0.202 
Hos Day  (d) 11.65±7.25 9.82±5.66 10.54±7.73 10.16+6.32 
 
 Prot Nr   19.20±0.62 21.40±1.46 23.33±1.92 21.59±1.88 <0.001 
Max Prot grad 33.50±11.8 27.91±9.89 23.69±8.2 27.34±9.97 0.022 
CPB-cardio pulmonary bypass; IT-ischemic time; Resp Ass-respiratory assistance; ICU –
intensive care unit; Hos –hospital; Prot Nr-prosthesis number; Max Prot grad-maximal 
transprosthetic gradient 
 
The following diagrams show correlation of 
PPM with the patient's age, BMI, BSA, the number of 
prosthesis, gender. 
 
Figure 1: Correlation between age and the possibility of PPM 
occurrence. We have an inverse relation between age and EOAi 
(EOAi=SEPi) 
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Discussion 
 
This is the first time that the incidence of PPM 
in aortic valve surgery has been reported in Albania. It 
is 10.3% for severe PPM and 67.8% for moderate 
PPM. Pibarot and Dumesnil refers that the incidence 
of severe PPM varies 2-11 % whereas that of 
moderate PPM 20-70% [2]. In separate studies, the 
incidence of severe and moderate PPM is referred 
respectively 2.3% -6.8% and 8.5% -58.7% [8-14].  
 
Figure 2: Correlation between PPM and BMI. Greater BMI - higher 
the possibility of PPM occurrence. 
 
We note that EOAi values that are taken as 
point references for the presence or not of PPM were 
different in various studies and they range from 0.7-
0,85cm2 / m
2
. In our study we used traditional point of 
references: 0.65cm2 / m
2
 ≤EOAi≤0.85cm
2
 / m
2
 for 
moderate PPM and EOAi < 0.65 cm
2
 / m
2
 for severe 
PPM. It seems that in our study group who underwent 
isolated aortic valve surgery, the PPM incidence is 
similar to other clinics. It remains an usual 
phenomenon. 
 
Figure 3: Correlation between the number of prostheses and PPM. 
It is clear that the smaller the number, greater probability of 
occurrence PPM. Small prosthesis number is significant risk factor 
for the occurrence of PPM 
 
The fact that this is common occurrence 
opened the debate about its impact on the results of 
aortic valve surgery. This debate is nowadays still 
open. 
In our study, the majority of the indicators of 
early operative results such as mortality, low cardiac 
output, pulmonary complications, bleeding, atrial 
fibrillation and wound infection have higher incidence 
with the patient-prosthesis mismatch group compared 
with the group without this phenomenon. The overall 
mortality is 3.1% while in the group with severe PPM 
mortality was 5% in the group with moderate PPM 
3.1% and for the group without PPM 2.4%. 
Kaminishi et al, in a study, which involved 
3609 patients with isolated aortic valve surgery, refer 
early mortality 2.2% for the group without PPM and 
3.9% for the group with PPM. These are similar to our 
results. Despite mortality in the group with the PPM is 
greater, this difference is not significant. PPM 
importantly affects only the duration of stay in 
intensive care unit and respiratory assistance [8]. 
Jamienson et al in a series of 3343 patients concluded 
that early mortality independent risk factors are age, 
NYHAIII-IV, simultaneous coronary surgery, type of 
prosthesis, COPD, renal insufficiency and diabetes 
mellitus. PPM is not part of the risk factors for early 
mortality and even more the phenomenon does not 
affect long-term outcomes [9]. In addition, post-
operative complications such as haemorrhage, stroke 
or complete atria-ventricular block, as well as in our 
study, are not affected by the presence of PPM [10]. 
There are also many smaller studies that support 
these results. In addition, PPM does not affect even 
the response of left ventricle muscle mass in the long-
term follow-up [15]. Results of aortic valve surgery are 
satisfactory in the presence of 76% incidence of PPM 
[16]. 
At the same time, there are many studies, 
which refer PPM as an important risk factor in early 
results of aortic valve surgery [11, 13, 16-18].  Walther 
et al, in a study where were included 4131 patients, of 
which 1856 used mechanical prosthesis and 2275 
biological prosthesis, analyzed the impact of PPM in 
early mortality of aortic valve surgery. Mortality for 
each group according to PPM degree was 5.2% in the 
group with severe PPM, 10.6% in the group with 
moderate PPM and 6.9% without PPM. Statistical 
analysis compared group with moderate PPM and 
without PPM and the difference was significant (p = 
0.018). This group clearly concludes that PPM is an 
important risk factor in early mortality of aortic valve 
surgery based upon other factors such as emergency 
surgery, euro score greater than 10, age greater than 
70 years old and simultaneous surgical procedures. 
This study recommended using information on 
specific prosthesis and specific data for each patient 
in order to avoid the PPM. In that context, various 
techniques can be used ranging from aortic valve 
annulus enlargement to surgery the aortic root [13].  
Hernandez et al in a study very similar to this 
study, noticed that the mortality in the group with PPM 
was approximately 8.2%, while in the group without 
PPM, was 0.7%, with significant difference (p = 
0.004), while for complications such as acute 
myocardial infarction, stroke, bleeding, post operative 
atrial fibrillation, pneumonia, the need for respiratory 
assistance, there is a tendency to have a higher 
incidence in the group with PPM and some of these 
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differences are important and similar to this study. In 
conclusion, this group refers PPM as an important 
negative risk factor in early results in aortic valve 
surgery [16]. PPM is closely related with hospital 
mortality and cardiac events [11]. Supporting these 
findings is the group of Toronto who refer 8% mortality 
rate for patients with PPM and 5% in the group 
without MPP (p = 0.003). The last two groups referred 
to the moderate PPM and recommend the need to 
prevent the occurrence of PPM [17].  
An interesting study that was published by 
Foster and colleagues, which refer that PPM 
increases operative mortality not significantly, but 
PPM impairs importantly muscle mass regress and in 
conditions when hypertrophy is an important risk 
factor for mortality, PPM may be a risk factor [14]. 
Patient-prosthesis mismatch should be analyzed 
together with patient characteristics. Urso and 
colleagues in a review associated with the effects of 
PPM concluded that severe PPM should be always 
avoided while moderate MPP can be tolerated except 
in cases of impaired cardiac function [19]. 
The controversy regarding the impact of early 
results of prosthesis- patient mismatch will probably 
continue. In this study, it seems that even PPM is a 
usual occurrence and does not influence negatively 
these results. Maybe in the future we will need to 
study this argument in special groups of patients such 
as in elderly patients or in patients with important left 
ventricle dysfunction. Furthermore, to determine the 
attitude towards PPM, it is very important to study this 
impact in long-term results of aortic valve surgery.  
In conclusion, patient-prosthesis mismatch is 
a common occurrence in aortic valve surgery. This 
phenomenon does not affect the early results of aortic 
valve surgery. 
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